The Evaluation of Psychiatric Illness in Asian Patients by the Hospital Anxiety Depression Scale

1989 ◽  
Vol 155 (4) ◽  
pp. 545-547 ◽  
Author(s):  
Salim Nayani
Keyword(s):  
Psychiatric Illness ◽  
Psychiatric Patients ◽  
Depression Scale ◽  
Somatic Symptoms ◽  
Hospital Anxiety ◽  
Interview Schedule ◽  
Asian Patients ◽  
Hospital Anxiety Depression Scale ◽  
Anxiety Depression ◽  
Had Scale

Twenty Asian psychiatric patients suffering from neurotic illness completed the Urdu version of the HAD Scale. The results were compared with the Clinical Interview Schedule. Somatic symptoms were significantly related to various measures of anxiety but not to those of depression. This finding contradicts the previously held view of linking somatic symptoms with the presentation of depression.

scholarly journals Psychiatric morbidity in primary care

1999 ◽  
Vol 5 (1) ◽  
pp. 21-26
Author(s):  
M. K. Al Haddad ◽  
A. Al Garf ◽  
S. Al Jowder ◽  
F. I. Al Zurba
Keyword(s):  
Psychiatric Illness ◽  
General Health Questionnaire ◽  
Psychiatric Morbidity ◽  
Depression Scale ◽  
Health Questionnaire ◽  
Hospital Anxiety ◽  
Primary Health ◽  
Hospital Anxiety Depression Scale ◽  
Anxiety Depression ◽  
Had Scale

The prevalence of hidden psychiatric morbidity was assessed using the General Health Questionnaire [GHQ]and Hospital Anxiety Depression Scale [HAD]. A total of 149 Bahraini patients aged > or = 16 years were selected randomly from those attending primary health care centres for problems other than psychiatric illness. The prevalence of psychiatric morbidity using GHQ was 45.1% [cut-off > or = 5]and 27.1% [cut-off > or = 9]. Using the HAD scale, the prevalence was 44.4% [cut-off > or = 8]and 23.6% [cut-off > or = 11]. Psychiatric morbidity was more common in women aged 50-55 years, in divorcees or widows and in lesser educated patients. Either instrument could be used to diagnose psychiatric illness

scholarly journals Association Between Hospital Anxiety Depression Scale and Autonomic Recovery Following Exercise

2019 ◽  
Vol 27 (2) ◽  
pp. 295-304
Author(s):  
Milana D. R. Santana ◽  
David M. Garner ◽  
Yasmim M. de Moraes ◽  
Luana B. Mangueira ◽  
Guilherme C. Alcantara ◽  
...  
Keyword(s):  
Depression Scale ◽  
Hospital Anxiety ◽  
Hospital Anxiety Depression Scale ◽  
Anxiety Depression

scholarly journals PENGARUH IMPLEMENTASI PROGRAM PRO-SELF TERHADAP KECEMASAN DAN DEPRESI PASIEN KEMOTERAPI

2017 ◽  
Vol 1 (2) ◽  
pp. 127
Author(s):  
Jihanni Mustika Mawardani ◽  
Haryani . ◽  
Probosuseno .
Keyword(s):  
Depression Scale ◽  
Wilcoxon Test ◽  
Anxiety And Depression ◽  
Oncology Group ◽  
Hospital Anxiety ◽  
Hospital Anxiety Depression Scale ◽  
Post Test ◽  
Information Skills ◽  
Chemotherapy Patients ◽  
Anxiety Depression

ABSTRAKLatar belakang: Kemoterapi menimbulkan efek samping fi siologis dan psikologis. Gejala psikologis yang dapatterjadi berupa kecemasan dan depresi. Masalah psikososial dapat diatasi dengan memfasilitasi peningkatankoping pasien melalui pemberian informasi dan peningkatan sistem dukungan. Program PRO–SELF yangdidesain untuk pasien kanker dewasa meliputi informasi, keterampilan, dan dukungan supaya penderitakanker dapat terlibat mandiri secara efektif dan konsisten dalam mengelola efek samping kemoterapi sehinggakeparahan gejala yang berhubungan dengan penyakitnya atau penanganan penyakitnya dapat diminimalkan.Tujuan: mengetahui pengaruh implementasi Program PRO-SELF terhadap kecemasan dan depresi padapasien kemoterapi. Metode: penelitian quasi eksperimen dengan pre-test-post-test one group design yangmelibatkan 40 responden selama 3 bulan dengan kriteria inklusi semua pasien kemoterapi, berusia kurangdari 65 tahun, nilai skala Eastern Cooperative Oncology Group (ECOG) 0–2. Data dikumpulkan pada bulanJuli–September 2013 di Ruang Penyakit Dalam IRNA 1 RSUP Dr. Sardjito. Kriteria eksklusinya pasien kankeryang memiliki riwayat gangguan psikiatri. Responden diberikan pre-test, kemudian diberikan intervensi olehpeneliti berupa pemberian program PRO-SELF yang terdiri atas pemberian informasi, keterampilan tentangkemoterapi dan pengurangan efek samping kemoterapi, serta pemberian dukungan melalui telepon saatpasien di rumah. Setelah intervensi, responden diberikan post-test dengan jarak waktu 3 minggu dari pretest. Pengukuran kecemasan dan depresi menggunakan kuesioner hospital anxiety depression scale (HADS).Analisis data dilakukan dengan analisis Wilcoxon Test dengan tingkat kepercayaan 95%. Hasil: Terdapatperbedaan bermakna tingkat kecemasan pada responden (p=0,001) dari pre-test ke post-test. Tingkat depresitidak bermakna dari pre-test ke post-test (p=0,258). Kesimpulan: Implementasi program PRO-SELF secaraefektif dapat mengurangi kecemasan pasien kemoterapi, tetapi tidak dapat secara efektif mengurangi depresi.Kata Kunci: kemoterapi, kecemasan, depresi, program PRO-SELF.ABSTRACTBackground: Chemotherapy causes physiological and psychological side effects. Psychological symptomsthat can occur are anxiety and depression. Psychosocial problems can be overcame by improved patient copingthrough the provision of information and improved support system. PRO-SELF program that was designedincrease self-care skills for adult patients undergoing cancer therapy includes information, skills, and support socancer patients can be engaged effectively and consistently independent in managing side effect chemotherapy,so the severity of symptoms due to disease or treatment disease can be minimized. Objectives: To identify theeffect of implementation PRO-SELF program to anxiety and depression in chemotherapy patients. Methods:This study used pre-experimental, one-group pre-test-post-test design involving 40 respondents for 3 month,inclusion criteria in this study are all chemotherapy patients, aged less than 65 years, screening patients withEastern Cooperative Oncology Group (ECOG 0–2) scale. Data were collected within July–September 2013 inInternal Injuries IRNA 1 Room RSUP Dr. Sardjito Yogyakarta. Exclusion criteria is cancer patients who havehistory of psychiatric disorder. Respondents were given a pre-test, then were given intervention by nursingstudent with provision of information, skills in reducing chemotherapy side effects, and provide support withtelephone when patients are at home. Respondent were given post-test after intervention 3 weeks after pretest. Measurement of anxiety and depression using hospital anxiety depression scale (HADS) questionnairesand analyzed with Wilcoxon test with 95% level of signifi cancy. Results: Decrease respondents anxiety frompre-test to post-test with signifi cancy 0.001, there is signifi cant difference. Depression respondents changedfrom pre-test to post-test with signifi cancy 0.258, that is non-signifi cant difference. Discussion: PRO-SELFprogram effectively reduce anxiety because information, skills, support can reduce anxiety. Conclusions:Implementation of the PRO-SELF program effectively reduce patient anxiety chemotherapy. Yet it can notreduce depression effectively.Keywords: chemotherapy, anxiety, depression, PRO-SELF program.

scholarly journals Structure and invariance of the Hospital Anxiety Depression Scale (HADS) in adolescents

2021 ◽  
Author(s):  
Andre Faro ◽  
Ludgleydson Fernandes de Araújo ◽  
Silvana Carneiro Maciel ◽  
Tiago Jessé Souza de Lima ◽  
Luana Elayne Cunha de Souza
Keyword(s):  
Clinical Sample ◽  
Depression Scale ◽  
Factorial Structure ◽  
Hospital Anxiety ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Gender Invariance ◽  
Hospital Anxiety Depression Scale ◽  
And Gender ◽  
Anxiety Depression

The main objective of this study was to test the factorial structure and gender invariance of the Hospital Anxiety Depression Scale (HADS) in a non-clinical sample of 657 adolescents (Mage = 16.3 years; SD = 1.19). The research design was an instrumental investigation, based on a cross-sectional survey with a sample of adolescents in Brazil. The results presented satisfactory evidence of the validity of the factorial structure and gender invariance for the sample. The composite reliability was also satisfactory, and no problems were detected related to common method bias. The mean of the items explained variance was .31 (31 %), with a Cronbach’s Alpha at .84 for the total scale, .81 and .69 for the anxiety and depression subscales, respectively. In the discussion, we analyzed questions related to the average variance extracted of the scale, which was lower than expected. Thus, we conclude that the current findings provide validity evidence to the application of the HADS with Brazilian adolescents for clinical or research purposes.  

Frequency and characteristics of drowsiness, somnolence, or daytime sleepiness in patients with advanced cancer

2018 ◽  
Vol 17 (04) ◽  
pp. 459-463 ◽  
Author(s):  
Sriram Yennurajalingam ◽  
Srikanth Reddy Barla ◽  
Joseph Arthur ◽  
Gary B. Chisholm ◽  
Eduardo Bruera
Keyword(s):  
Quality Index ◽  
Pittsburgh Sleep Quality Index ◽  
Depression Scale ◽  
Well Being ◽  
Severity Index ◽  
Hospital Anxiety ◽  
Hospital Anxiety Depression Scale ◽  
Clinically Significant ◽  
Anxiety Depression ◽  
Insomnia Severity

AbstractIntroductionCancer-related drowsiness (CRD) is a distressing symptom in advanced cancer patients (ACP). The aim of this study was to determine the frequency and factors associated with severity of CRD. We also evaluated the screening performance of Edmonton Symptom Assessment Scale-drowsiness (ESAS-D) item against the Epworth Sedation Scale (ESS).MethodWe prospectively assessed 180 consecutive ACP at a tertiary cancer hospital. Patients were surveyed using ESAS, ESS, Pittsburgh Sleep Quality Index, Insomnia Severity Index, and Hospital Anxiety Depression Scale.ResultNinety of 150 evaluable patients had clinically significant CRD (ESS); median (interquartile ratio): ESS. 11 (7–14); ESAS-D. 5 (2–6); Pittsburgh Sleep Quality Index. 8 (5–11); Insomnia Severity Index. 13 (5–19); Stop Bang Scoring 3 (2–4), and Hospital Anxiety Depression Scale-D 6 (3–10). ESAS-D was associated with ESAS (r, p) sleep (0.38, <0.0001); pain (0.3, <0.0001); fatigue (0.51, <0.0001); depression (0.39, <0.0001); anxiety (0.44, <0.0001); shortness of breath (0.32, <0.0001); anorexia (0.36, <0.0001), feeling of well-being [(0.41, <0.0001), ESS (0.24, 0.001), and opioid daily dose (0.19, 0.01). Multivariate-analysis showed ESAS-D was associated with fatigue (odds ratio [OR] = 9.08, p < 0.0001), anxiety (3.0, p = 0.009); feeling of well-being (OR = 2.27, p = 0.04), and insomnia (OR = 2.35; p = 0.036). Insomnia (OR = 2.35; p = 0.036) cutoff score ≥3 (of 10) resulted in a sensitivity of 81% and 32% and specificity of 70% and 44% in the training and validation samples, respectively.Significance of resultsClinically significant CRD is frequent and seen in 50% of ACP. CRD was associated with severity of insomnia, fatigue, anxiety, and worse feeling of well-being. An ESAS-D score of ≥3 is likely to identify most of the ACP with significant CRD.

Sign in / Sign up

Export Citation Format

Share Document